Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia